نتایج جستجو برای: dota

تعداد نتایج: 2399  

2010
Sang Young Jeong Hyo Jeong Kim Byung-Kook Kwak Ha-Young Lee Hasoo Seong Byung Cheol Shin Soon Hong Yuk Sung-Joo Hwang Sun Hang Cho

Biocompatible poly-[N-(2-hydroxyethyl)-d,l-aspartamide]-methoxypoly(ethyleneglycol)-hexadecylamine (PHEA-mPEG-C(16)) conjugated with 1,4,7,10-tetraazacyclododecan-1,4,7,10-tetraacetic acid-gadolinium (DOTA-Gd) via ethylenediamine (ED) was synthesized as a magnetic resonance imaging (MRI) contrast agent. Amphiphilic PHEA-mPEG-C(16)-ED-DOTA-Gd forms micelle in aqueous solution. All the synthesize...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001
R Stein S V Govindan S Chen L Reed H Richel G L Griffiths H J Hansen D M Goldenberg

UNLABELLED Tumor targeting and therapeutic efficacy of (177)Lu-labeled monoclonal antibody (mAb) RS7 (antiepithelial glycoprotein-1) was evaluated in a human nonsmall cell lung carcinoma xenograft model. The potential of (177)Lu-labeled RS7 was compared with that of RS7 labeled with (90)Y and a residualizing form of (131)I. METHODS A 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid...

Journal: :Nuclear medicine and biology 2014
Morten Persson Henrik H El Ali Tina Binderup Andreas Pfeifer Jacob Madsen Palle Rasmussen Andreas Kjaer

UNLABELLED (64)Cu-DOTA-AE105 is a novel positron emission tomography (PET) tracer specific to the human urokinase-type plasminogen activator receptor (uPAR). In preparation of using this tracer in humans, as a new promising method to distinguish between indolent and aggressive cancers, we have performed PET studies in mice to evaluate the in vivo biodistribution and estimate human dosimetry of ...

2017
Aurelie Maisonial-Besset Tiffany Witkowski Isabelle Navarro-Teulon Odile Berthier-Vergnes Giovanna Fois Yingying Zhu Sophie Besse Olivia Bawa Arnaud Briat Mercedes Quintana Alexandre Pichard Mathilde Bonnet Eric Rubinstein Jean-Pierre Pouget Paule Opolon Lydia Maigne Elisabeth Miot-Noirault Jean-Michel Chezal Claude Boucheix Françoise Degoul

Tetraspanin 8 (TSPAN8) overexpression is correlated with poor prognosis in human colorectal cancer (CRC). A murine mAb Ts29.2 specific for human TSPAN8 provided significant efficiency for immunotherapy in CRC pre-clinical models. We therefore evaluate the feasability of targeting TSPAN8 in CRC with radiolabeled Ts29.2. Staining of tissue micro-arrays with Ts29.2 revealed that TSPAN8 espression ...

2017
Tarek Z. Bass Maria Rosestedt Bogdan Mitran Fredrik Y. Frejd John Löfblom Vladimir Tolmachev Stefan Ståhl Anna Orlova

Overexpression of human epidermal growth factor receptor 3 (HER3) is involved in resistance to several therapies for malignant tumours. Currently, several anti-HER3 monoclonal antibodies are under clinical development. We introduce an alternative approach to HER3-targeted therapy based on engineered scaffold proteins, i.e. affibody molecules. We designed a small construct (22.5 kDa, denoted 3A3...

2010
Jing Zou Rohit Sood Sanjeev Ranjan Dennis Poe Usama A Ramadan Paavo KJ Kinnunen Ilmari Pyykkö

BACKGROUND Treatment of inner ear diseases remains a problem because of limited passage through the blood-inner ear barriers and lack of control with the delivery of treatment agents by intravenous or oral administration. As a minimally-invasive approach, intratympanic delivery of multifunctional nanoparticles (MFNPs) carrying genes or drugs to the inner ear is a future therapy for treating inn...

2015
Hiroaki Kurihara Akinobu Hamada Masayuki Yoshida Schuichi Shimma Jun Hashimoto Kan Yonemori Hitomi Tani Yasuji Miyakita Yousuke Kanayama Yasuhiro Wada Makoto Kodaira Mayu Yunokawa Harukaze Yamamoto Chikako Shimizu Kazuhiro Takahashi Yasuyoshi Watanabe Yasuhiro Fujiwara Kenji Tamura

BACKGROUND The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. METHODS PET was performed on five patients with brain metastases from HER2-positive breast cancer, at 24 or 48 h after th...

2014
Johnnie J. Orozco Ethan R. Balkin Ted A. Gooley Aimee Kenoyer Donald K. Hamlin D. Scott Wilbur Darrell R. Fisher Mark D. Hylarides Mazyar Shadman Damian J. Green Ajay K. Gopal Oliver W. Press John M. Pagel

Radioimmunotherapy (RIT) for treatment of hematologic malignancies has primarily employed monoclonal antibodies (Ab) labeled with 131I or 90Y which have limitations, and alternative radionuclides are needed to facilitate wider adoption of RIT. We therefore compared the relative therapeutic efficacy and toxicity of anti-CD45 RIT employing 90Y and 177Lu in a syngeneic, disseminated murine myeloid...

2015
Kelsey Herrmann Mette L. Johansen Sonya E. Craig Jason Vincent Michael Howell Ying Gao Lan Lu Bernadette Erokwu Richard S. Agnes Zheng-Rong Lu Jonathan K. Pokorski James Basilion Vikas Gulani Mark Griswold Chris Flask Susann M. Brady-Kalnay

Magnetic resonance imaging (MRI) of glioblastoma multiforme (GBM) with molecular imaging agents would allow for the specific localization of brain tumors. Prior studies using T 1-weighted MR imaging demonstrated that the SBK2-Tris-(Gd-DOTA)3 molecular imaging agent labeled heterotopic xenograft models of brain tumors more intensely than non-specific contrast agents using conventional T 1-weight...

Journal: :Hellenic journal of nuclear medicine 2009
Margarita Pagou Imene Zerizer Adil Al-Nahhas

The development of gallium-68 -1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid ((68)Ga-DOTA) compounds was made possible due to the chemistry of (68)Ga, which matches the pharmacokinetics of many peptides, specially the chelators DOTA and DOTAderivatives with the formation of stable (68)Ga (3+) complexes. The availability of this tracer from a germanium-68-gallium-68 generator with a rel...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید